Theravance Biopharma Inc. (TBPH) fell -7.91% or -2.22 to $25.83. It is around 227424 shares traded, which is 90.46% compare to the average total volume 251405. The market cap of TBPH is $1.40 billion. The year to date change is -0.07%. The 52 week price range is from $22.9 to $43.44. Price of TBPH have changed -0.57% during last week. It have changed -3.21% over last month, -0.64% over last 3 months, -5.59% over last 6 months and -12.32% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 27.70. It is 7.24% above current price. The 200-day Moving Averages for TBPH is 31.83. It is 23.23% above current price. The 52-week High is 43.44. It is 68.18% from the current price. The 52-week Low is 22.9. It is -11.34% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of TBPH is 42.27 on 2018-01-31. Short % to float is 11.74%. There are some statistics of TBPH. It is has market cap $1.40 billion. The share outstanding is 54.10 million. The average volume is 251405. The revenue is 16.56M. The gross profit is 12.50M. The percent of top 15 Institution holding is 81.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -107.35%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -61.94%.